Get the Stockscreener App
0.262
2.60%
-0.007
Petros Pharmaceuticals Inc stock is traded at $0.262, with a volume of 176.35K.
It is down -2.60% in the last 24 hours and down -36.11% over the past month.
Petros Pharmaceuticals Inc is a men's health pharmaceutical company. It focuses on therapeutics that promote medication adherence, tolerability, and preservation of male organic function. The company's operating segment includes Prescription Medications and Medical Devices. It generates maximum revenue from the Medical Devices segment. The Prescription Medications segment consists of operations related to vacuum erection devices, which are sold domestically and internationally.
See More
Previous Close:
$0.269
Open:
$0.262
24h Volume:
176.35K
Relative Volume:
0.09
Market Cap:
$3.04M
Revenue:
$4.02M
Net Income/Loss:
$-4.73M
P/E Ratio:
-0.0622
EPS:
-4.21
Net Cash Flow:
$-5.85M
1W Performance:
-6.33%
1M Performance:
-36.11%
6M Performance:
-24.00%
1Y Performance:
-76.81%
1-Day Range:
$0.25
$0.2849
1-Week Range:
$0.25
$0.2902
52-Week Range:
$0.2208
$2.27
Petros Pharmaceuticals Inc Stock (PTPI) Company Profile
Name
Petros Pharmaceuticals Inc
Sector
Phone
973-242-0005
Address
1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK
Compare PTPI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PTPI
Petros Pharmaceuticals Inc
|
0.2621 | 3.04M | 4.02M | -4.73M | -5.85M | -4.21 |
|
ZTS
Zoetis Inc
|
171.49 | 78.56B | 9.15B | 2.43B | 2.31B | 5.32 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.54 | 43.15B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
9.545 | 43.00B | 14.26B | 1.55B | 0 | 0.3383 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.66 | 19.59B | 16.54B | -1.64B | 749.00M | -1.45 |
|
NBIX
Neurocrine Biosciences Inc
|
124.02 | 15.24B | 2.24B | 385.90M | 440.10M | 3.73 |
Petros Pharmaceuticals Inc Stock (PTPI) Latest News
Analytical Lens: Exploring Perella Weinberg Partners (PWP)’s Financial Story Through Ratios - The Dwinnex
Petros Pharmaceuticals Inc’s (PTPI) Stock: A Week-by-Week Analysis - The News Heater
Petros Pharmaceuticals Strategically Positioned to Benefit as Technology Leader from Newly Approved FDA OTC Final Rules - ACCESS Newswire
Petros Pharmaceuticals Successfully Completes Important Study in Effort to Make STENDRA(R) (avanafil) the First Erectile Dysfunction Medication to Achieve OTC Status - ACCESS Newswire
Johnson & Johnson posts Q4 beat as drug sales offset MedTech weakness - MSN
Harmony Biosciences chief commercial officer sells shares worth $1.15m - MSN
Microvast files for $250M mixed securities shelf offering - MSN
Petros Pharmaceuticals modifies terms with investors By Investing.com - Investing.com India
Janbelco BV trims stake in Thalassa Holdings - MSN
Immedica to buy Marinus Pharmaceuticals for $151m - MSN
XORTX Therapeutics Announces Auditor Transition - MSN
Apellis Pharmaceuticals executive sells $36,998 in stock - MSN
Amneal gets FDA approval for generic Byetta, resubmits DHE NDA - MSN
Pharming Group appoints former Novartis USA President Fabrice Chouraqui as New CEO - MSN
Takeda-backed Ascentage Pharma targets $1.75 billion valuation in US IPO - MSN
Vincerx Pharma enters at-the-market equity offering deal - MSN
Mitsubishi Chemical picks Bain as preferred bidder for pharma unit, sources say - MSN
Sanofi receives GMP warning letter for Genzyme facility - MSN
Sinopharm Accord Projects Notable Profit Decline for 2024 - MSN
Comparing Petros Pharmaceuticals (NASDAQ:PTPI) & MoonLake Immunotherapeutics (NASDAQ:MLTX) - Defense World
AstraZeneca's Calquence gains FDA nod for 1L MCL treatment - MSN
FDA grants tentative approval for Amneal generic of Bausch Health's Xiafan - MSN
GoodRx Holdings announces CFO resignation; shares drop - MSN
Petronas may cut capex up to RM10b after Petro gas deal - The Malaysian Reserve
5 Best-performing Canadian Pharma Stocks (Updated January 2025) - MSN
Pre-market Movers: SANA, SLDB, JSPR, DRIO... - RTTNews
AMRN Stock Rises Over 5% Amidst Lack of Institutional Ratings - GuruFocus.com
GROUPIRA Co-Founder Petros Koumantaros Appointed to Washington Saves Governing Board - Yahoo Finance
Best Penny Stocks for Today (Charts Updated Daily) - Benzinga
Pre-market Movers: ONCO, COEP, NUVB, SPRC... - RTTNews
Psychedelic Drug Therapy May Address Mental Health Concerns in People with Cancer & Addiction - NYU Langone Health
Siga Technologies (SIGA) Stock Surges Over 5% Amid Market Activi - GuruFocus.com
Petros Pharmaceuticals Featured in “New Era of Healthcare, AI, Data and Consumer Empowerment” - AccessWire
Why Sangamo Therapeutics Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket - Benzinga
Siga Technologies (SIGA) Stock Drops 5.01% Amid Market Volatilit - GuruFocus.com
Why Corvus Pharmaceuticals Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket - Benzinga
Falcon’s Beyond Global Announces Mandatory Exchange of WarrantsOn December 16, 2024, Falcon’s Beyond Global, Inc. (NASDAQ: FBYD) made a significant announcement regarding the mandatory exchange of its outstanding warrants. The company reve - Defense World
Proprietary Technology Addressing the Rx-to-OTC Switch Self-Care Market Valued at over $38 Billion annually - AccessWire
Petros Pharmaceuticals faces financial obligation acceleration - Investing.com
Petros Pharmaceuticals, Inc. Announces Proprietary Technology Addressing the Rx-To-OTC Switch Self-Care Market Valued at over $38 Billion Annual - Marketscreener.com
Tarsus Pharmaceuticals: Worthy Of A Small Bet (NASDAQ:TARS❌ Ilumine seu dia com Estrela BRT - Oficjalny Portal Gminy Brzesko
Petros Pharmaceuticals faces financial obligation acceleration By Investing.com - Investing.com UK
Why Mitek Systems Shares Are Trading Higher By Around 19%; Here Are 20 Stocks Moving Premarket - Benzinga
Pre-market Movers: EWTX, TNXP, LNSR, VRDN... - RTTNews
Helios Towers (LON:HTWS) Trading 0.1% Higher – Should You Buy? - Defense World
Cleanaway Waste Management (OTCMKTS:TSPCF) Stock Price Up 2.2% – Should You Buy? - Defense World
First National of Nebraska (OTCMKTS:FINN) Trading 0.8% Higher – Should You Buy? - Defense World
Petros Pharmaceuticals (NASDAQ:PTPI) Stock Price Down 5.8% – Should You Sell? - Defense World
Kuke Music (NYSE:KUKE) Shares Down 8.3% – Time to Sell? - Defense World
Patriot One Technologies (OTCMKTS:PTOTF) Stock Price Down 2.1% – What’s Next? - Defense World
Catalent wins EU approval for planned $16.5B sale to Novo Holdings - MSN
Petros Pharmaceuticals Inc Stock (PTPI) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.12%
2.84%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):